MJ

Active Director Director DIN 08657857
DIN 08657857 First appointment Jan 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Manna Jha

Data last updated:

Manna Jha is a Director at Uthika Laboratories Private Limited (since 2020). The company operates in Pharma. Uthika Laboratories Private Limited reported revenue of ₹1.91 Cr (FY 2025).

DIN 08657857
Primary Designation Director
Industry Pharma
First Appointment 03 Jan 2020
Oldest Company Age 6 yrs
Largest company Uthika Laboratories Private Limited · ₹1.91 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Uthika Laboratories Private Limited U24304UR2020PTC010613
Director03 Jan 20202020₹1.91 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Uthika Laboratories Private Limited
Premium access

Shareholding and investment profile for Manna Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manna Jha

Manna Jha currently holds 1 directorship: Uthika Laboratories Private Limited (Director, since 03 Jan 2020, revenue ₹1.91 Cr (FY 2025)).

Manna Jha was first appointed on 03 Jan 2020 as Director at Uthika Laboratories Private Limited.

The current boards of Manna Jha's companies include Arundeep Singh Chaudhary (Uthika Laboratories Private Limited), Vijan Bir Singh Chauhan (Uthika Laboratories Private Limited), Vinod Chandra (Uthika Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available